Collectively, these studies provide converging evidence that Hsp90 plays critical roles in the pathophysiology of autoimmune bullous skin diseases by supporting pathogenic autoantibody production, neutrophil effector functions, and keratinocyte inflammatory responses. This evidence concerns the gene HSP90AB1 and autoimmune bullous skin disease.